Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.7K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

582
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
582
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

636
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
636
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Cross-bridge Cycle01:26

Cross-bridge Cycle

117.9K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.9K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Cancer Therapy and Accelerated Brain Aging: Mechanisms, Biomarkers, and Clinical Consequences.

Current oncology (Toronto, Ont.)·2026
Same author

Diffusion Tensor Tractography Shows White Matter Tract Changes in Breast Cancer Survivors with Balance Impairment.

Pathophysiology : the official journal of the International Society for Pathophysiology·2025
Same author

[Study of neurodegeneration in multiple sclerosis using optical coherence tomography of the retina and magnetic resonance morphometry of the brain].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Phenotypic heterogeneity of Charcot-Marie-Tooth type 2A disease associated with the c.1091G>C missense mutation (p.Arg364Pro) in the MFN2 gene].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Challenges of differential diagnosis in the verification of Behçet's disease with neurological manifestations].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

MRI Voxel Morphometry Shows Brain Volume Changes in Breast Cancer Survivors: Implications for Treatment.

Pathophysiology : the official journal of the International Society for Pathophysiology·2025

Related Experiment Video

Updated: Aug 8, 2025

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

32.0K

[Multiple system atrophy].

M P Topuzova1, I K Ternovykh1, T A Shustova1

  • 1Almazov National Medical Research Centre, St Petersburg, Russia.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|February 27, 2023
PubMed
Summary

Multisystem atrophy (MSA) is a progressive neurodegenerative disease. Early diagnosis of MSA, characterized by autonomic failure and motor disorders like parkinsonism or cerebellar ataxia, is crucial for personalized patient management and improved quality of life.

Keywords:
MSAdiagnosticsmultiple system atrophyneuroimagingorthostatic hypotensionparkinsonismα-synuclein

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.5K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K

Related Experiment Videos

Last Updated: Aug 8, 2025

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

32.0K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.5K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K

Area of Science:

  • Neurology
  • Neurodegeneration

Context:

  • Multisystem atrophy (MSA) is a rare, progressive neurodegenerative disorder.
  • It presents with a combination of autonomic dysfunction and motor impairments, including parkinsonism and/or cerebellar ataxia.
  • Clinical presentation varies, complicating diagnosis.

Purpose:

  • To describe the clinical features and diagnostic challenges of multisystem atrophy.
  • To present a case study of a 59-year-old patient with complex MSA symptoms.
  • To highlight the importance of early and accurate diagnosis for patient management.

Summary:

  • The article details multisystem atrophy (MSA), a progressive neurodegenerative disease.
  • A case of a 59-year-old patient with cerebellar and bulbar syndromes, parkinsonism, cognitive deficits, and autonomic dysfunction is presented.
  • The diagnosis of MSA, cerebellar type, was established after considering differential diagnoses including Parkinson's disease and spinocerebellar ataxia.

Impact:

  • Accurate diagnosis of MSA is challenging due to overlapping symptoms with other neurodegenerative diseases.
  • Early diagnosis is vital for developing personalized management strategies.
  • Timely intervention can improve survival time and quality of life for MSA patients.